Downregulation of the IFNAR1 chain of type 1 interferon receptor contributes to the maintenance of the haematopoietic stem cells

References

• Passegue E, Wagers AJ, Giuriato S, Anderson WC, Weissman IL. Global analysis of proliferation and cell cycle gene expression in the regulation of hematopoietic stem and progenitor cell fates. J Exp Med 2005; 202:1599-611; PMID:16330818; https://doi.org/10.1084/jem.20050967
   PubMed Web of Science ®Google Scholar
• Huang X, Cho S, Spangrude GJ. Hematopoietic stem cells: generation and self-renewal. Cell Death Differ 2007; 14:1851-9; PMID:17823616; https://doi.org/10.1038/sj.cdd.4402225
   PubMed Web of Science ®Google Scholar
• Cheshier SH, Morrison SJ, Liao X, Weissman IL. In vivo proliferation and cell cycle kinetics of long-term self-renewing hematopoietic stem cells. Proc Natl Acad Sci U S A 1999; 96:3120-5; PMID:10077647; https://doi.org/10.1073/pnas.96.6.3120
   PubMed Web of Science ®Google Scholar
• Matsumoto A, Nakayama KI. Role of key regulators of the cell cycle in maintenance of hematopoietic stem cells. Biochim Biophys Acta 2013; 1830:2335-44; PMID:22820018; https://doi.org/10.1016/j.bbagen.2012.07.004
   PubMed Web of Science ®Google Scholar
• Suda T, Takubo K, Semenza GL. Metabolic regulation of hematopoietic stem cells in the hypoxic niche. Cell Stem Cell 2011; 9:298-310; PMID:21982230; https://doi.org/10.1016/j.stem.2011.09.010
   PubMed Web of Science ®Google Scholar
• Arai F, Hirao A, Ohmura M, Sato H, Matsuoka S, Takubo K, Ito K, Koh GY, Suda T. Tie2/angiopoietin-1 signaling regulates hematopoietic stem cell quiescence in the bone marrow niche. Cell 2004; 118:149-61; PMID:15260986; https://doi.org/10.1016/j.cell.2004.07.004
   PubMed Web of Science ®Google Scholar
• Kiel MJ, Yilmaz OH, Iwashita T, Yilmaz OH, Terhorst C, Morrison SJ. SLAM family receptors distinguish hematopoietic stem and progenitor cells and reveal endothelial niches for stem cells. Cell 2005; 121:1109-21; PMID:15989959; https://doi.org/10.1016/j.cell.2005.05.026
   PubMed Web of Science ®Google Scholar
• Baldridge MT, King KY, Boles NC, Weksberg DC, Goodell MA. Quiescent haematopoietic stem cells are activated by IFN-gamma in response to chronic infection. Nature 2010; 465:793-7; PMID:20535209; https://doi.org/10.1038/nature09135
   PubMed Web of Science ®Google Scholar
• Sato T, Onai N, Yoshihara H, Arai F, Suda T, Ohteki T. Interferon regulatory factor-2 protects quiescent hematopoietic stem cells from type I interferon-dependent exhaustion. Nat Med 2009; 15:696-700; PMID:19483695; https://doi.org/10.1038/nm.1973
   PubMed Web of Science ®Google Scholar
• Essers MA, Offner S, Blanco-Bose WE, Waibler Z, Kalinke U, Duchosal MA, Trumpp A. IFNalpha activates dormant haematopoietic stem cells in vivo. Nature 2009; 458:904-8; PMID:19212321; https://doi.org/10.1038/nature07815
   PubMed Web of Science ®Google Scholar
• Fuchs SY. Hope and fear for interferon: The receptor-centric outlook on the future of interferon therapy. J Interferon Cytokine Res 2013; 33:211-25; PMID:23570388; https://doi.org/10.1089/jir.2012.0117
   PubMed Web of Science ®Google Scholar
• Kumar KG, Tang W, Ravindranath AK, Clark WA, Croze E, Fuchs SY. SCF(HOS) ubiquitin ligase mediates the ligand-induced down-regulation of the interferon-alpha receptor. EMBO J 2003; 22:5480-90; PMID:14532120; https://doi.org/10.1093/emboj/cdg524
   PubMed Web of Science ®Google Scholar
• Kumar KG, Krolewski JJ, Fuchs SY. Phosphorylation and specific ubiquitin acceptor sites are required for ubiquitination and degradation of the IFNAR1 subunit of type I interferon receptor. J Biol Chem 2004; 279:46614-20; PMID:15337770; https://doi.org/10.1074/jbc.M407082200
   PubMed Web of Science ®Google Scholar
• Kumar KG, Barriere H, Carbone CJ, Liu J, Swaminathan G, Xu P, Li Y, Baker DP, Peng J, Lukacs GL, et al. Site-specific ubiquitination exposes a linear motif to promote interferon-alpha receptor endocytosis. J Cell Biol 2007; 179:935-50; PMID:18056411; https://doi.org/10.1083/jcb.200706034
   PubMed Web of Science ®Google Scholar
• Kumar KG, Varghese B, Banerjee A, Baker DP, Constantinescu SN, Pellegrini S, Fuchs SY. Basal ubiquitin-independent internalization of interferon alpha receptor is prevented by Tyk2-mediated masking of a linear endocytic motif. J Biol Chem 2008; 283:18566-72; PMID:18474601; https://doi.org/10.1074/jbc.M800991200
   PubMed Web of Science ®Google Scholar
• Liu J, Plotnikov A, Banerjee A, Suresh Kumar KG, Ragimbeau J, Marijanovic Z, Baker DP, Pellegrini S, Fuchs SY. Ligand-independent pathway that controls stability of interferon alpha receptor. Biochem Biophys Res Commun 2008; 367:388-93; PMID:18166147; https://doi.org/10.1016/j.bbrc.2007.12.137
   PubMed Web of Science ®Google Scholar
• Liu J, Carvalho LP, Bhattacharya S, Carbone CJ, Kumar KG, Leu NA, Yau PM, Donald RG, Weiss MJ, Baker DP, et al. Mammalian casein kinase 1alpha and its leishmanial ortholog regulate stability of IFNAR1 and type I interferon signaling. Mol Cell Biol 2009; 29:6401-12; PMID:19805514; https://doi.org/10.1128/MCB.00478-09
   PubMed Web of Science ®Google Scholar
• Liu J, HuangFu WC, Kumar KG, Qian J, Casey JP, Hamanaka RB, Grigoriadou C, Aldabe R, Diehl JA, Fuchs SY. Virus-induced unfolded protein response attenuates antiviral defenses via phosphorylation-dependent degradation of the type I interferon receptor. Cell Host Microbe 2009; 5:72-83; PMID:19154989; https://doi.org/10.1016/j.chom.2008.11.008
   PubMed Web of Science ®Google Scholar
• Bhattacharya S, HuangFu WC, Liu J, Veeranki S, Baker DP, Koumenis C, Diehl JA, Fuchs SY. Inducible priming phosphorylation promotes ligand-independent degradation of the IFNAR1 chain of type I interferon receptor. J Biol Chem 2010; 285:2318-25; PMID:19948722; https://doi.org/10.1074/jbc.M109.071498
   PubMed Web of Science ®Google Scholar
• Bhattacharya S, Qian J, Tzimas C, Baker DP, Koumenis C, Diehl JA, Fuchs SY. Role of p38 protein kinase in the ligand-independent ubiquitination and down-regulation of the IFNAR1 chain of type I interferon receptor. J Biol Chem 2011; 286:22069-76; PMID:21540188; https://doi.org/10.1074/jbc.M111.238766
   PubMed Web of Science ®Google Scholar
• Bhattacharya S, Zheng H, Tzimas C, Carroll M, Baker DP, Fuchs SY. Bcr-abl signals to desensitize chronic myeloid leukemia cells to IFNalpha via accelerating the degradation of its receptor. Blood 2011; 118:4179-87; PMID:21821707; https://doi.org/10.1182/blood-2010-12-325373
   PubMed Web of Science ®Google Scholar
• Qian J, Zheng H, Huangfu WC, Liu J, Carbone CJ, Leu NA, Baker DP, Fuchs SY. Pathogen recognition receptor signaling accelerates phosphorylation-dependent degradation of IFNAR1. PLoS Pathog 2011; 7:e1002065; PMID:21695243; https://doi.org/10.1371/journal.ppat.1002065
   PubMed Web of Science ®Google Scholar
• Zheng H, Qian J, Baker DP, Fuchs SY. Tyrosine phosphorylation of protein kinase D2 mediates ligand-inducible elimination of the Type 1 interferon receptor. J Biol Chem 2011; 286:35733-41; PMID:21865166; https://doi.org/10.1074/jbc.M111.263608
   PubMed Web of Science ®Google Scholar
• Zheng H, Qian J, Carbone CJ, Leu NA, Baker DP, Fuchs SY. Vascular endothelial growth factor-induced elimination of the type 1 interferon receptor is required for efficient angiogenesis. Blood 2011; 118:4003-6; PMID:21832278; https://doi.org/10.1182/blood-2011-06-359745
   PubMed Web of Science ®Google Scholar
• Huangfu WC, Qian J, Liu C, Liu J, Lokshin AE, Baker DP, Rui H, Fuchs SY. Inflammatory signaling compromises cell responses to interferon alpha. Oncogene 2012; 31:161-72; PMID:21666722; https://doi.org/10.1038/onc.2011.221
   PubMed Web of Science ®Google Scholar
• Bhattacharya S, HuangFu WC, Dong G, Qian J, Baker DP, Karar J, Koumenis C, Diehl JA, Fuchs SY. Anti-tumorigenic effects of Type 1 interferon are subdued by integrated stress responses. Oncogene 2013; 32:4214-21; PMID:23045272; https://doi.org/10.1038/onc.2012.439
   PubMed Web of Science ®Google Scholar
• Zheng H, Qian J, Varghese B, Baker DP, Fuchs S. Ligand-stimulated downregulation of the alpha interferon receptor: Role of protein kinase D2. Mol Cell Biol 2011; 31:710-20; PMID:21173164; https://doi.org/10.1128/MCB.01154-10
   PubMed Web of Science ®Google Scholar
• Katlinskaya YV, Katlinski KV, Lasri A, Li N, Beiting DP, Durham AC, Yang T, Pikarsky E, Lengner CJ, Johnson FB, et al. Type I interferons control proliferation and function of the intestinal epithelium. Mol Cell Biol 2016; 36:1124-35; PMID:26811327; https://doi.org/10.1128/MCB.00988-15
   PubMed Web of Science ®Google Scholar
• Yu Q, Zhao B, Gui J, Katlinski KV, Brice A, Gao Y, Li C, Kushner JA, Koumenis C, Diehl JA, et al. Type I interferons mediate pancreatic toxicities of PERK inhibition. Proc Natl Acad Sci U S A 2015; 112:15420-5; PMID:26627716; https://doi.org/10.1073/pnas.1516362112
   PubMed Web of Science ®Google Scholar
• Bhattacharya S, Katlinski KV, Reichert M, Takano S, Brice A, Zhao B, Yu Q, Zheng H, Carbone CJ, Katlinskaya YV, et al. Triggering ubiquitination of IFNAR1 protects tissues from inflammatory injury. EMBO Mol Med 2014; 6:384-97; PMID:24480543; https://doi.org/10.1002/emmm.201303236
   PubMed Web of Science ®Google Scholar
• Schneider RK, Adema V, Heckl D, Jaras M, Mallo M, Lord AM, Chu LP, McConkey ME, Kramann R, Mullally A, et al. Role of casein kinase 1A1 in the biology and targeted therapy of del(5q) MDS. Cancer Cell 2014; 26:509-20; PMID:25242043; https://doi.org/10.1016/j.ccr.2014.08.001
   PubMed Web of Science ®Google Scholar
• Pietras EM, Reynaud D, Kang YA, Carlin D, Calero-Nieto FJ, Leavitt AD, Stuart JM, Gottgens B, Passegue E. Functionally distinct subsets of lineage-biased multipotent progenitors control blood production in normal and regenerative conditions. Cell Stem Cell 2015; 17:35-46; PMID:26095048; https://doi.org/10.1016/j.stem.2015.05.003
   PubMed Web of Science ®Google Scholar
• Kronke J, Fink EC, Hollenbach PW, MacBeth KJ, Hurst SN, Udeshi ND, Chamberlain PP, Mani DR, Man HW, Gandhi AK, et al. Lenalidomide induces ubiquitination and degradation of CK1alpha in del(5q) MDS. Nature 2015; 523:183-8; PMID:26131937; https://doi.org/10.1038/nature14610
   PubMed Web of Science ®Google Scholar
• Lindner S, Kronke J. The molecular mechanism of thalidomide analogs in hematologic malignancies. Journal of molecular medicine 2016; 94:1327-34; PMID:27492707; https://doi.org/10.1007/s00109-016-1450-z
   PubMed Web of Science ®Google Scholar
• Petzold G, Fischer ES, Thoma NH. Structural basis of lenalidomide-induced CK1alpha degradation by the CRL4(CRBN) ubiquitin ligase. Nature 2016; 532:127-30; PMID:26909574; https://doi.org/10.1038/nature16979
   PubMed Web of Science ®Google Scholar